Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics Munich, |
RCV000995648 | SCV001149942 | pathogenic | Hereditary spastic paraplegia 7 | 2019-06-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001091056 | SCV001246895 | pathogenic | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | SPG7: PVS1, PM3:Strong, PM2 |
Labcorp Genetics |
RCV000995648 | SCV001390280 | pathogenic | Hereditary spastic paraplegia 7 | 2022-05-16 | criteria provided, single submitter | clinical testing | Disruption of this splice site has been observed in individuals with spastic paraplegia (PMID: 20108356, 31407473). ClinVar contains an entry for this variant (Variation ID: 807498). Studies have shown that disruption of this splice site results in mRNA lacking exon 11 and introduces a premature termination codon (PMID: 20108356). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. This variant is present in population databases (rs141644720, gnomAD 0.004%). This sequence change affects a donor splice site in intron 11 of the SPG7 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or disrupted protein product. |
Paris Brain Institute, |
RCV000995648 | SCV001451055 | pathogenic | Hereditary spastic paraplegia 7 | criteria provided, single submitter | clinical testing | ||
Institute of Medical Genetics and Applied Genomics, |
RCV001091056 | SCV001905572 | pathogenic | not provided | 2021-09-15 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV000995648 | SCV001949993 | pathogenic | Hereditary spastic paraplegia 7 | 2021-04-08 | criteria provided, single submitter | clinical testing | This variant was identified as compound heterozygous with NM_003119.4:c.1529C>T. |
Genome Diagnostics Laboratory, |
RCV001847130 | SCV002105847 | likely pathogenic | Hereditary spastic paraplegia | 2018-09-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000995648 | SCV002785427 | pathogenic | Hereditary spastic paraplegia 7 | 2021-07-12 | criteria provided, single submitter | clinical testing | |
PROSPAX |
RCV000995648 | SCV005044581 | pathogenic | Hereditary spastic paraplegia 7 | 2022-01-01 | criteria provided, single submitter | research | |
Zotz- |
RCV000995648 | SCV004101096 | pathogenic | Hereditary spastic paraplegia 7 | 2023-11-02 | no assertion criteria provided | clinical testing |